| 000 | 01872 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518044102.0 | ||
| 264 | 0 | _c20200721 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1502-7708 | ||
| 024 | 7 |
_a10.1080/00365521.2019.1629006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Asseldonk, Dirk P | |
| 245 | 0 | 0 |
_aLimited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients. _h[electronic resource] |
| 260 |
_bScandinavian journal of gastroenterology _cJun 2019 |
||
| 300 |
_a753-760 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFocal Nodular Hyperplasia _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Portal _xchemically induced |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 |
_aThioguanine _xadministration & dosage |
| 700 | 1 | _aSimsek, Melek | |
| 700 | 1 | _ade Boer, Nanne K H | |
| 700 | 1 | _aJharap, Bindia | |
| 700 | 1 | _aBloemena, Elisabeth | |
| 700 | 1 | _aden Hartog, Gijsbert | |
| 700 | 1 | _aWesterveld, Dik B | |
| 700 | 1 | _aBecx, Marco C | |
| 700 | 1 | _aRussel, Maurice G | |
| 700 | 1 | _aLissenberg-Witte, Birgit I | |
| 700 | 1 | _avan Nieuwkerk, Carin M | |
| 700 | 1 | _aMulder, Chris J J | |
| 700 | 1 | _aVerheij, Joanne | |
| 700 | 1 | _avan Bodegraven, Adriaan A | |
| 773 | 0 |
_tScandinavian journal of gastroenterology _gvol. 54 _gno. 6 _gp. 753-760 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00365521.2019.1629006 _zAvailable from publisher's website |
| 999 |
_c29802886 _d29802886 |
||